Chemical Structure For Lansoprazole (3e029e9f 0db0 41b7 8552 4728da9bad78 01)
Lansoprazole
Product Images NDC 54868-6205
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 54868-6205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (3e029e9f 0db0 41b7 8552 4728da9bad78 02)
This is a graph showing the mean severity of daytime heartburn over a period of days from the start of treatment. There are three treatment groups: placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. The severity of heartburn is measured on the Y-axis and the number of days from the start of treatment is on the X-axis.*
Figure 2 (3e029e9f 0db0 41b7 8552 4728da9bad78 03)
This is a chart showing the mean severity of night heartburn for patients taking a placebo, e-lansoprazole 15 mg QD, and 4-lansoprazole 30 mg QD over 60 days from the start of treatment.*
Lansoprazole Delayed-release Orally Disintegrating Tablets 30 mg (6205)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
